Epigral (EPIGRAL.BO) Earnings Analysis
Epigral (EPIGRAL.BO) next reports earnings on 2026-07-27. Last quarter (2026-05-02) it beat with EPS 19 INR vs 14.3 INR est (+32.9%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E 14.90.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does EPIGRAL.BO next report earnings?
| Next earnings date | 2026-07-27 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 7.62B |
EPIGRAL.BO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-02 | 19 INR | 14.3 INR | +32.9% | Beat |
| 2026-01-30 | 9.1 INR | 7.3 INR | +24.7% | Beat |
| 2025-09-30 | 11.87 INR | 14.1 INR | -15.8% | Miss |
| 2025-06-30 | 37.25 INR | 17.45 INR | +113.5% | Beat |
| 2025-05-05 | 20.14 INR | 20.3 INR | -0.8% | Miss |
| 2025-01-27 | 24.25 INR | 19.4 INR | +25% | Beat |
| 2024-11-10 | 19.57 INR | n/a | n/a | n/a |
| 2024-07-24 | 20.67 INR | n/a | n/a | n/a |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
EPIGRAL.BO valuation and analyst view
| Trailing P/E | 14.90 |
|---|---|
| Trailing EPS | 76.934 INR |
| Price / book | 2.23 |
| Dividend yield | 0.44% |
| Market cap | 49.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Epigral (EPIGRAL.BO)'s next earnings date?
Epigral is next scheduled to report on 2026-07-27 and revenue estimate of 7.62B.
Did EPIGRAL.BO beat earnings last quarter?
In its 2026-05-02 report, EPIGRAL.BO posted EPS of 19 INR versus a 14.3 INR estimate — a beat of 32.9%.
What is EPIGRAL.BO's earnings track record?
Over the last 6 reported quarters with consensus data, EPIGRAL.BO beat estimates 4 times (67%).
What is EPIGRAL.BO's current P/E ratio and EPS?
EPIGRAL.BO trades at a trailing P/E of 14.90 on trailing EPS of 76.93395133256084 INR.
What do analysts rate EPIGRAL.BO?
EPIGRAL.BO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.